FeesSafety
Pluang+

Graphic Packaging posts slight sales growth but sees net income drop in Q3 2026, expects full-year improvement.

Company Fundamentals
03 Nov 2026, 13:30 WIB
PRNewsWire
View Source
Neutral
Graphic Packaging posts slight sales growth but sees net income drop in Q3 2026, expects full-year improvement.

Graphic Packaging Holding Company reported a slight increase in net sales to $2.192 billion in Q3 2026, up 1% year-over-year, but net income fell sharply to $22 million from $142 million due to higher costs and special charges. Adjusted EBITDA declined to $289 million with margin pressure from inflation and pricing challenges. The company reaffirmed its full-year 2026 guidance, expecting net sales of $8.6 billion, adjusted EBITDA of $1.05 billion, and adjusted EPS of $0.65, supported by cost reductions and productivity improvements. Strong cash flow and debt reduction efforts position the company for margin recovery and growth in 2027.

Graphic Packaging Holding Company's Q3 2026 financial results provide context for readers. For those following the Consumer Staples sector, here is Pluang's market snapshot as of Nov 03, 2026 17:11 WIB: Among 63 priced US stocks, 13 rose and 42 fell. Notable movers include XXII at USD 0.07 with a 5.56% decline, BF.B at USD 28.59 down 4.70%, and OTLY at USD 8.00 up 3.76%.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App